Close observation versus upfront treatment in hepatocellular carcinoma: Are the exception points worth the risk?

Danielle M. Tholey, Ben Hornung, Charles K. Enestvedt, Yiyi Chen, Willscott S. Naugler, Khashayar Farsad, Nima Nabavizadeh, Barry Schlansky, Joseph Ahn, Janice H. Jou

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Close observation versus upfront treatment in hepatocellular carcinoma: Are the exception points worth the risk?'. Together they form a unique fingerprint.

Medicine & Life Sciences